Febrile neutropenia at the emergency department of a cancer hospital;La fièvre chez les patients se présentant aux urgences d'un hôpital cancérologique: Place de la neutropénie fébrile

Revue Medicale de Bruxelles

Volumn 32, Issue 2, 2011, Pages 74-82

  Debey, C ^a,b   Meert, A P ^a   Berghmans, T ^a   Thomas, J M ^b   Sculier, J P ^a  

^a JULES BORDET INSTITUTE   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Cancer; Emergencies; Febrile neutropenia; Primary care

Indexed keywords

ANTIBIOTIC AGENT;

ARTICLE; CANCER CENTER; CANCER CHEMOTHERAPY; CLINICAL FEATURE; DISEASE SEVERITY; EMERGENCY CARE; FEBRILE NEUTROPENIA; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; RISK FACTOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; EMERGENCIES; EMERGENCY SERVICE, HOSPITAL; FEMALE; FEVER; HOSPITALS, SPECIAL; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; NEUTROPENIA; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 79956295206     PISSN: 00353639     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Biron P, Fuhrmann C, Escande MC et al. : Standards, options et recommandations pour la prise en charge des neutropénies courtes. Bull Cancer 1998 ; 85 : 695-711 (Pubitemid 28427769)
2. Halfdanarson TR, Hogan WJ, Moynihan TJ : Oncologic emergencies : diagnosis and treatment. Mayo Clin Proc 2006 ; 81 : 835-48
3. Hughes WT, Armstrong D, Bodey GP et al. : 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2003 ; 34 : 730-51 (Pubitemid 34194843)
4. Samphao S, Eremin JM, Eremin O : Oncological emergencies : clinical importance and principles of management. Eur J Cancer Care (Engl ) 2010 ; 19 : 707-13
5. Herbrecht R : Prise en charge de l'épisode fébrile chez le patient neutropénique. Presse Med 1998 ; 27 : 1306-8
6. Higdon ML, Higdon JA : Treatment of oncologic emergencies. Am Fam Physician 2006 ; 74 : 1873-80 (Pubitemid 44885895)
7. Klastersky J, Paesmans M, Georgala A et al. : Outpatient oral antibiotics for febrile neutropenic cancer patients using a score predictive for complications. J Clin Oncol 2006 ; 24 : 4129-34 (Pubitemid 46622289)
8. Perrone J, Hollander JE, Datner EM : Emergency Department evaluation of patients with fever and chemotherapy-induced neutropenia. J Emerg Med 2004 ; 27 : 115-9 (Pubitemid 38917192)
9. Courtney DM, Aldeen AZ, Gorman SM et al. : Cancer-associated neutropenic fever : clinical outcome and economic costs of emergency department care. Oncologist 2007 ; 12 : 1019-26 (Pubitemid 47359145)
10. Bodey GP, Buckley M, Sathe YS, Freireich EJ : Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966 ; 64 : 328-40
11. Klastersky J, Paesmans M : Risk-adapted strategy for the management of febrile neutropenia in cancer patients. Support Care Cancer 2007 ; 15 : 477-82 (Pubitemid 46570785)
12. Klastersky J : Management of fever in neutropenic patients with different risks of complications. Clin Infect Dis 2004 ; 39 (Suppl 1) : S32-7
13. Di MM, Perrone F, Chiodini P et al. : Individual patient data metaanalysis of docetaxel administered once every 3 weeks compared with once every week second-line treatment of advanced non-small-cell lung cancer. J Clin Oncol 2007 ; 25 : 1377-82 (Pubitemid 46706885)
14. Klastersky J, Paesmans M, Rubenstein EB et al. : The Multinational Association for Supportive Care in Cancer risk index : A multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol 2000 ; 18 : 3038-51
15. Beck KE, Blansfield JA, Tran KQ et al. : Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4. J Clin Oncol 2006 ; 24 : 2283-9
16. Forget F : Place du médecin généraliste dans la prise en charge des patients cancéreux en 2008 ? Revue Médecine Générale 2008 ; 253 : 202-9
17. Sebban C, Dussart S, Fuhrmann C et al. : Oral moxifloxacin or intravenous ceftriaxone for the treatment of low-risk neutropenic fever in cancer patients suitable for early hospital discharge. Support Care Cancer 2008 ; 16 : 1017-23